Related Experiment Videos
Pleiotropic effects of fibrates
Giulia Chinetti-Gbaguidi1, Jean Charles Fruchart, Bart Staels
1UR 545 INSERM, Institut Pasteur de Lille, 1 rue Calmette BP245, 59019 Lille, France.
Current Atherosclerosis Reports
|August 18, 2005
Summary
Fibrates, a class of hypolipidemic drugs, activate PPARa to regulate lipid metabolism and reduce inflammation. This leads to significant reductions in cardiovascular disease, improving patient outcomes.
Area of Science:
- Pharmacology
- Molecular Biology
- Cardiovascular Medicine
Background:
- Fibrates are commonly prescribed hypolipidemic agents.
- Their mechanism involves activating the peroxisome proliferator-activated receptor alpha (PPARa).
Purpose of the Study:
- To elucidate the molecular mechanisms of fibrate action.
- To highlight the clinical benefits of fibrates in cardiovascular disease prevention.
Main Methods:
- Analysis of gene transcription modulation by fibrates.
- Investigation of PPARa-mediated signaling pathways.
- Review of clinical trial data on fibrate efficacy.
Main Results:
- Fibrates modulate genes involved in lipid transport and metabolism.
- Fibrates exhibit anti-inflammatory effects by downregulating inflammatory cytokines.
- Clinical trials show reduced cardiovascular morbidity and mortality.
Conclusions:
- Fibrates offer significant cardiovascular benefits through PPARa activation.
- Combined lipid-lowering and anti-inflammatory actions contribute to clinical efficacy.
- Fibrates represent a valuable therapeutic option for managing dyslipidemia and reducing cardiovascular risk.